✦ LIBER ✦

O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts

✍ Scribed by Clemons, M; Kelly, J; Watson, A J; Howell, A; McElhinney, R S; McMurry, T B H; Margison, G P

Book ID: 109998649
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 115 KB
Volume: 93
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602833

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The multidrug resistance of tumour cells

The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells

✍ L.W Fu; Y.M Zhang; Y.J Liang; X.P Yang; Q.C Pan 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 223 KB

The P140K mutant of human O6-methylguani

The P140K mutant of human O6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O6-(4-bromothenyl)guanine

✍ Lorna B. Woolford; Thomas D. Southgate; Geoffrey P. Margison; Michael D. Milsom; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

The O 6 -methylguanine-DNA-methyltransferase (MGMT) inactivator O 6benzylguanine (O 6 -beG) is currently under clinical investigation as a potential tumour-sensitising agent. In clinical trials its use has been associated with increased myelotoxicity and a reduced maximum tolerated dose (MTD) for BC